News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    

Biotech/Pharma - Investor (World)
Innocoll, Inc. (INNL) Announces Pricing Of Follow-On Offering 4/24/2015
Nordic Nanovector – Share Capital Increase Registered 4/24/2015
Change In BioTie Therapies Corp.' Financial Calendar 2015 4/23/2015
Change In The Number Of Votes Relating To BioTie Therapies Corp.'s Shares 4/23/2015
The Nomination Committee’s Proposals To The Annual General Meeting In Karo Bio AB 4/23/2015
Horizon Pharma (HZNP) Announces Closing Of Public Offering Of Ordinary Shares And Full Exercise Of Underwriters' Option To Purchase Additional Shares 4/23/2015
Buy Vertex (VRTX) Now for $45B Or Risk It All, Analyst Tells Gilead (GILD) 4/22/2015
Tiziana Life Sciences Plc Release: Issue Of Convertible Loan Notes And Warrants 4/22/2015
Annual General Meeting In BioInvent (BOVNF) 4/22/2015
Foamix Pharmaceuticals, Ltd. (FOMX) Announces Closing Of Its $69 Million Public Offering Of Ordinary Shares 4/20/2015
Admedus Completes Fully Subscribed $16.1 Million Rights Issue 4/17/2015
Ipsen (IPN.PA), Active Biotech AB (BTPC) Plummet As Prostate Cancer Drug Flunks Late-Stage Trial 4/17/2015
Nuvo Research Inc. (NRI.TO) Updates Company Strategy 4/16/2015
Foamix Pharmaceuticals, Ltd. (FOMX) Announces Upsizing And Pricing Of Its $60 Million Public Offering Of Ordinary Shares 4/15/2015
WuXi PharmaTech Co., Ltd. Files 2014 Annual Report On Form 20-F 4/15/2015
uniQure (QURE) Announces Pricing Of Follow-On Public Offering 4/10/2015
Cellular Biomedicine Group (CBMG) Upgraded To NASDAQ Global Market 4/10/2015
Resolutions Of The Annual Shareholders’ Meeting Of Sartorius AG 4/9/2015
Replicel Life Sciences Receives TSX Venture Exchange Approval To Extend Warrant Expiry Dates 4/8/2015
Prothena (PRTA) Announces Pricing Of Public Offering Of 3,300,000 Ordinary Shares 4/8/2015
Lonza Group Ltd. (LZAGY.PK) Announces Results Of Annual General Meeting Annual General Meeting Accepts All Motions Proposed By Board Of Directors 4/8/2015
“Batten Down the Hatches” But Look For Opportunity in Rough First Quarter, Says Analyst 4/8/2015
Prothena (PRTA) Announces Proposed Offering of Ordinary Shares 4/7/2015
Teva (TEVA)'s Recent Moves Suggest Restructuring Will Focus on Hypertension, Respiratory & CNS Markets 4/6/2015
Analyst: A Complete List of All Major Biosimilars Could Be the A to Z Guide 4/6/2015
Mallinckrodt (MNK) Launches Notes Offering 4/6/2015
WuXi PharmaTech Co., Ltd. Lists Shares Of Small-Molecule Manufacturing Subsidiary STA On New Third Board In China 4/3/2015
Amgen (AMGN) in the Crosshairs As Biogen (BIIB), Hospira, Merck & Co. (MRK) All Climb on Biosimilar Bandwagon: Citi 4/2/2015
Trinity Biotech plc Announces Proposed Offering Of $100 Million Of Exchangeable Senior Notes Due 2045 4/2/2015
Salix (SLXP) Provides Notice of Fundamental Changes, Make-Whole Fundamental Changes And Merger Event Relating To Its 1.5% Convertible Senior Notes Due 2019 4/2/2015
Foamix Pharmaceuticals, Ltd. (FOMX) Files Registration Statement For Proposed Follow-On Offering 4/2/2015
BTG plc (BTG.L): Close Period Update 4/2/2015
Valeant (VRX) Completes Tender Offer For Salix (SLXP) 4/1/2015
Trillium Therapeutics Inc. Announces Pricing Of Public Offering Of Securities 4/1/2015
Cardio3 BioSciences Announces Intention To Conduct A Registered Public Offering In The United States 4/1/2015
NeuroVive Pharmaceutical AB (publ) - Amendment Number Of Shares And Votes 3/31/2015
Horizon Pharma (HZNP) To Acquire Hyperion Therapeutics (HPTX) For $46.00 Per Share Or $1.1 Billion In Cash 3/30/2015
MorphoSys AG Tanks 20% on Celgene (CELG) Cancer Pact Breakup News 3/30/2015
Innocoll AG Secures EUR 25 Million Loan Commitment From European Investment Bank (EIB) 3/30/2015
Covalon Technologies Ltd. Announces Issuance Of Stock Options 3/30/2015
Analyst: First Quarter Market Meltdown Just "Clockwork," As Biogen (BIIB), Celgene (CELG) Reign 3/27/2015
CAR-T, Checkpoint Inhibitors and Vaccines All Key at Crucial Conference, Says Cowen and Company 3/27/2015
BioPharm Executive: Why Your Last Investment Blew Up 3/26/2015
Notice of General Meeting In Probi AB (publ) 3/25/2015
Nordic Nanovector: Nano – Mandatory Notification Of Trade 3/25/2015
Newron Pharmaceuticals (NWRN) Shareholders Authorize Allocation Of Additional Shares To Support Multiple Clinical Programs 3/24/2015
Biogen (BIIB) Slides For Alzheimer's Drug Wow Analysts, Set Up Fight for Eli Lilly (LLY) 3/23/2015
Convening Notice For 2015 Annual General Meeting In Precise Biometrics AB (Publ) 3/23/2015
Notice Of Annual General Meeting In Bioinvent International AB 3/23/2015
TiGenix: Convening Notice To The Annual And The Extraordinary Shareholders' Meeting To Be Held On 20 April 2015 3/20/2015
Nordic Nanovector: Nano – Mandatory Notification Of Trade 3/20/2015
Resolutions From The Annual General Meeting Of Novo Nordisk A/S (NVO) 3/19/2015
Admedus Announces Placement And Rights Issue 3/18/2015
MS Specialist Picks Biogen Idec (BIIB)’s Tecfidera and Plegridy, Teva (TEVA)’s Laquinimod: Analyst 3/17/2015
Valeant (VRX) Prices Offering Of $1.45 Billion Of Common Shares 3/17/2015
Valeant (VRX) Announces Offering Of $1.45 Billion Of Common Shares 3/17/2015
Polar Capital Funds Plc And Fmr Llc Provide Notification Of Shareholding In Ablynx (ABLYF) 3/16/2015
Change In The Number Of Votes Relating To BioTie Therapies Corp.'s Shares 3/16/2015
Oxford BioMedica PLC (OXB.L) Director's Share Purchase 3/16/2015
Notice of Annual General Meeting Of Orexo AB (ORXOF) 3/16/2015
Ablynx (ABLYF) Announces Warrant Exercise 3/16/2015
AmerisourceBergen Corporation (ABC) the “Pony to Ride” for Biosimilar Opportunities, Says UBS 3/16/2015
ThromboGenics NV (TBGNF) Full Year 2014 Business Update 3/13/2015
Replicel Life Sciences In Japan For Key Industry Meetings 3/12/2015
Capital Increase In Genmab A/S (GEN.CO) As A Result Of Employee Warrant Exercise And Projection Of Improved Cash Position At The End Of 2015 3/12/2015
Actavis (ACT) Announces Closing Of Public Offering Of Senior Notes In Connection With Pending Acquisition Of Allergan (AGN) 3/12/2015
Lonza Group Ltd. (LZAGY.PK) Publishes Annual Report 2014 And Invitation To The 2015 Annual General Meeting 3/11/2015
SYGNIS AG To Host Live Webinar On Its Revolutionary TrueprimeTechnology For Primer-Free Whole Genome Amplification (WGA) 3/11/2015
Valeant (VRX) Announces Launch Of Private Offering Of Senior Notes 3/10/2015
Horizon Pharma plc.  (HZNP) Prices Offering Of $350 Million Of 2.50% Exchangeable Senior Notes 3/9/2015
BioLineRx Ltd. Announces Underwritten Public Offering Of Its American Depositary Shares 3/6/2015
AEterna Zentaris (AEZS) Announces Pricing Of US$37 Million Public Offering Of Common Shares And Warrants 3/6/2015
Galapagos NV (GLPG.BR) To Be Included In Amsterdam Midcap Index 3/6/2015
PhytoTech Medical Limited (ASX:PYL) Investor Presentation 3/6/2015
AbbVie (ABBV) Overpaid in Pharmacyclics (PCYC) Deal, For Only 50% Rights to Imbruvica: Analyst 3/6/2015
Analyst: Docs Bullish On Roche (RHHBY)'s Perjeta and PD-1/PDL1, Cautious on Palbociclib and Neratinib 3/5/2015
Actavis (ACT) Announces Pricing Of Public Offering Of Senior Notes In Connection With Pending Acquisition Of Allergan (AGN) 3/4/2015
Neovacs SA Scientific Advisory Board Endorses Company's Updated IFNa-Kinoid Development Plan 3/4/2015
Actavis (ACT) Announces Closing Of Public Offerings Of Ordinary Shares And Mandatory Convertible Preferred Shares In Connection With Pending Acquisition Of Allergan (AGN) 3/3/2015
Mylan Inc. (MYL) Files Annual Report On Form 10-K For Year Ended Dec. 31, 2014 3/3/2015
Aviva Plc And Aviva Investors Global Services Limited Provide Notification Of A 5.02% Shareholding In Ablynx (ABLYF) 3/3/2015
Alnylam (ALNY)’s “Incredibly Deep” Pipeline Continues to Impress As Commercial Stage Looms, Says Analyst 3/2/2015
InMed To Present Investor Webcast March 5 3/2/2015
Karolinska Development AB Confirms Full Payment In The Rights Issue Of Convertibles 3/2/2015
Actavis (ACT) Announces Proposed Public Offering Of Senior Notes In Connection With Pending Acquisition Of Allergan (AGN) 3/2/2015
Tianyin Pharmaceutical Co, Inc. Received Notice Of Non-Compliance With NYSE MKT Continued Listing Requirements 2/27/2015
Teva Pharmaceutical Industries (TEVA) Announces Early Results Of Debt Tender Offer, Pricing, Election Of Early Settlement And Increase In Maximum Amount And Priority 2 Notes Tender Cap 2/27/2015
Presentation Of The Result Of Medivir AB (MVRBF)’s Voluntary Redemption Programme 2/27/2015
Cortendo AB: Cortendo Announces Notice Of Extraordinary General Meeting 2/27/2015
Cardio3 BioSciences To Raise Capital Via A Private Placement Of New Shares 2/26/2015
Actavis (ACT) Announces Pricing Of Public Offerings Of Ordinary Shares And Mandatory Convertible Preferred Shares In Connection With Pending Acquisition Of Allergan (AGN) 2/25/2015
Alkermes plc (ALKS) Announces Webcast Of Analyst And Investor Event On March 2, 2015 2/24/2015
GENFIT Corp. (ALGFT): Minutes Of The Combined General Shareholders' Meeting Of February 24, 2015 2/24/2015
Fake Quote Scandal: Medical Marijuana Firm CEN Biotech Receives Major Setback 2/20/2015
RedHill Biopharma Ltd. (RDHL) Announces Full Exercise Of Underwriters' Over-Allotment Option 2/18/2015
RedHill Biopharma Ltd. (RDHL) Announces Closing Of Public Offering Of Its American Depository Shares 2/13/2015
VolitionRX Announces Closing Of Public Offering Of Common Stock 2/12/2015
Transition Therapeutics Inc. (TTH.TO) Announces Pricing Of Public Offering Of US$20 Million Of Common Shares 2/12/2015
RedHill Biopharma Ltd. (RDHL) Prices Public Offering Of Its American Depository Shares 2/10/2015
RedHill Biopharma Ltd. (RDHL) Announces Proposed Public Offering Of Its American Depository Shares 2/10/2015
Suven Life Sciences Ltd Revenue Growth At 9% While PAT Is Down By 11.55% For The 3rd Quarter Ended Dec 2014 2/10/2015
BIOCEO15: Kite Pharma (KITE) Debuts Near-Term Plans, Says It’s Tackling "Toxicity Issues" 2/10/2015
BIOCEO15: New Report On Biotech Venture Capital Over Last 10 Years Finds Heavy Focus on R&D 2/10/2015
BIOCEO15: Sarepta (SRPT) CEO Feels Backlash After Saying Ebola Research Isn’t in "Shareholder Interest" 2/10/2015
BIOCEO15: Financial Panel Sees Deal-Making Up in 2015, Names CAR-T, Plaque Attackers as Hot Targets 2/9/2015
BNP Paribas Notify Of 5.08% Shareholding In Galapagos NV (GLPG.BR) 2/9/2015
VolitionRX Prices Public Offering of Common Stock 2/6/2015
Genmab A/S (GEN.CO) Release: Major Shareholder Announcement 2/5/2015
Express Scripts Inc. Cheers As Data Shows Drug Pricing Up 3-Fold, Even When Adjusted For Inflation, Survival 2/5/2015
Macrocure (MCUR) Announces Special General Meeting Of Shareholders For Approval Of Amendments To Compensation Package Of CEO And 2013 Share Incentive Plan 2/5/2015
Alkermes plc (ALKS)’ Corporate Presentation To Be Webcast At Two Upcoming Conferences 2/4/2015
Forget Smartphones—Genomic Data is the Next Big Deal, Says Edico Genome CEO 2/4/2015
Summit Corporation Files Registration Statement For Proposed U.S. Public Offering And Applies For NASDAQ Listing 2/2/2015
Admedus Release: Announcement To The Australian Stock Exchange 2/2/2015
Oxford Immunotec Limited (OXFD) Announces Proposed Underwritten Offering Of Ordinary Shares 1/29/2015
Future Of Healthcare Investor Forum Highlights Investment Opportunity In UK Life Sciences 1/29/2015
BioSpace (DHX)'s List of Five Companies to Watch in 2015: Aegerion (AEGR), AbbVie (ABBV), Tekmira (TKMR), Novartis AG (NVS), GlaxoSmithKline (GSK) 1/28/2015
Ascendis Pharma A/S Announces Pricing Of Initial Public Offering 1/28/2015
ESSA Pharma Inc. Lists On The TSX Venture Exchange 1/28/2015
AnaMar Announces Strategic Realignment And 2015 Corporate Priorities 1/28/2015
Oxford Immunotec Global PLC Announces Proposed Underwritten Offering Of Ordinary Shares 1/28/2015
Cortendo AB: Notification Of Trade 1/27/2015
Medivir AB (MVRBF)’s CEO Increases His Shareholding In The Company 1/27/2015
Amgen (AMGN) Beats Street’s Earnings Estimates, Ready for Biosimilars, Says Citi 1/27/2015
Scandal-Hit GlaxoSmithKline (GSK) to Chop 1,000 Staffers in China 1/27/2015
Ultimovacs Carries Out NOK 45 Million Share Issue With Canica AS And Sundt AS As The Main Investors 1/22/2015
Ablynx (ABLYF) Announces Warrant Exercise 1/21/2015
Endo International (ENDP) Announces Pricing of Private Offering Of Senior Notes 1/21/2015
Endo International (ENDP) Announces Proposed Private Offering Of Senior Notes 1/20/2015
NeuroDerm Ltd. (NDRM) Announces Extraordinary General Meeting Of Shareholders For Ratification Of Election Of External Directors And Adoption Of Compensation Policy 1/20/2015
Change In The Number Of Votes Relating To BioTie Therapies Corp.'s Shares 1/20/2015
Horizon Discovery Group plc Trading Update 1/19/2015
Valeant (VRX) Announces Pricing Of Private Offering Of Senior Notes 1/16/2015
Cortendo AB: Cortendo Announces Notice Of Extraordinary General Meeting 1/15/2015
Alcobra (ADHD) Announces Closing Of Public Offering Of Ordinary Shares And Full Exercise Of Over-Allotment Option 1/14/2015
Debiopharm Diagnostics Leads Investment Round In GenePOC With Emerillon Capital 1/14/2015
ProSensa Holding N.V. (RNA) Announces Shareholder Approval Of Certain Matters Relating To The BioMarin (BMRN) Tender Offer 1/13/2015
Cardio3 BioSciences To Host Investor & Analyst Day In New York On Friday, January 30, 2015 1/13/2015
Allergy Therapeutics plc Release: Trading Update 1/12/2015
Skyepharma PLC (SKYEF) Release: Pre-Close Update 1/12/2015
ERYtech Pharma Announces ADR Level 1 Listing In The U.S. 1/12/2015
Pluristem Therapeutics (PSTI) Issues Letter To Shareholders 1/12/2015
MGB Biopharma Limited Continues To Progress Its Truly Novel Anti-Infectives Platform To Tackle Antibiotic Resistance In 2014 1/12/2015
Fountain Healthcare's New €85 Million Fund to Create New Jobs in Biotech, Medtech 1/9/2015
Alcobra (ADHD) Announces Commencement Of Public Offering Of Ordinary Shares 1/9/2015
Alcobra (ADHD) Prices Public Offering Of Ordinary Shares 1/9/2015
China Biologic Products Adopts Stockholder Rights Plan 1/9/2015
Seventure Invests EUR 1 M (USD 1.25 M) In First Investment Round For MaaT Pharma™ 1/9/2015
EXCLUSIVE: Developing World Needs Different Pricing Model, Naia Limited CEO Tells BioSpace (DHX) 1/9/2015
TRANSGENE (ENX:TNG) Announces Financial Calendar For 2015 1/8/2015
Fundamentals Still Strong for Large Cap Biotech, But Headwinds Remain 1/7/2015
Pivotal Therapeutics Inc. Announces Payment Of Interest On Outstanding Convertible Notes 1/6/2015
The FDA’s Breakthrough Therapy Program By the Numbers 1/5/2015
Protalix Biotherapeutics, Inc. (PLX) Announces New Strategy For Accelerated Growth 1/5/2015
RedHill Biopharma Ltd. (RDHL) Business Outlook And Anticipated Key Milestones For 2015 1/5/2015
Enzymotec Announces An Extraordinary General Meeting Of Shareholders 1/5/2015
Biotech Investors Surge Happily Into New Year, “Frothy” or Not, Says Cowen 1/5/2015
Tianyin Pharmaceutical Co, Inc. Updates on Alliance Discussion 1/2/2015
AmpliPhi Biosciences Corporation (APHB) To Host Shareholder Update Conference Call 12/31/2014
Share Buybacks Could Save Gilead Sciences, Inc. (GILD) After Turbulent Two Weeks, Says Citi 12/30/2014
Change Of Number Of Shares And Votes In Karolinska Development AB 12/30/2014
Change In Number Of Shares And Votes In Meda AB (MEDA-A.ST) 12/30/2014
Bloodbath On Wall Street Over Drug Pricing Will Taper, Says Analyst 12/23/2014
AbbVie (ABBV)’s Access to Express Scripts Inc. a “Pyrrhic Victory,” Says Analyst 12/22/2014
Covidien plc (COV) Declares Quarterly Cash Dividend 12/22/2014
GlaxoSmithKline (GSK) Reassure Investors That Dividend Is Safe As Analysts Question Payout 12/19/2014
AEterna Zentaris (AEZS) Receives Notification From NASDAQ Relating To Minimum Bid Price 12/19/2014
Biotech Predictions for Large Cap Firms Include Medivation, Inc. (MDVN), Gilead Sciences, Inc. (GILD) 12/18/2014
2015 Could Be Blockbuster Year for Alkermes plc (ALKS), Says Citi 12/17/2014
K-Bro Declares December Dividend 12/16/2014
The Biotech Year in Review, According To Bernstein 12/16/2014
China Cord Blood Corporation Announces Results of 2014 Annual General Meeting 12/11/2014
Analysts Not Sold On Medivation, Inc. (MDVN)’s Xtandi as Breast Cancer Drug 12/10/2014
bluebird bio (BLUE)’s New Blood Treatment Could Benefit Sickle Cell, Says Analyst 12/9/2014
Karolinska Development AB Release: Purchase Of Own Shares To Cover Social Security Fees Related To Incentive Program 12/8/2014
Survey of Investors, Hedge Funds Blasé on Merck & Co. (MRK), Cubist Pharmaceuticals, Inc. (CBST) Deal 12/8/2014
Rubicon Hints At ArborGen IPO, Laments Skidding Share Price 12/5/2014
Drug Spending Still Under 10% of American Health Costs, Says Analyst 12/5/2014
GlaxoSmithKline (GSK) Abandons Planned Sale Of Established Products Portfolio 12/5/2014
Speculation Mounts That Pfizer (PFE) Will Up Bid For AstraZeneca PLC (AZN) As Cooling Off Period Ends 12/5/2014
WuXi PharmaTech Co., Ltd. Subsidiary Submits Application To The National Equities Exchange And Quotations In China To List On The New Third Board 12/4/2014
BTG plc (BTG.L) Results Of Placing 12/4/2014
DelMar Pharmaceuticals Joins OTCQX 12/3/2014
Is New Alzheimer’s Drug the Stabilizing Force Biogen Idec (BIIB) Needs? 12/3/2014
Analyst: Current Crop of Biotech IPOs a Mixed Bag of Low Market Caps, Little Data 12/3/2014
Perrigo (PRGO) Announces The Closing Of Its Registered Public Offering Of Senior Notes 12/3/2014
Teva Pharmaceutical Industries Limited (TEVA) To Host 2015 Business Outlook Conference Call And Webcast On December 11, 2014 12/2/2014
Valeant (VRX) Announces Redemption Of US$445.0 Million Aggregate Principal Amount Of Its Outstanding 6.875% Senior Notes Due 2018 12/1/2014
Immune Pharmaceuticals, Inc. Completes Underwriter's Exercise Of Partial Over-Allotment Option 12/1/2014
Roche Holdings, Inc. Announces Final Results Of Its Debt Tender Offer 12/1/2014
2015 Will Be A Defining Year for Gene Therapy, Says Analyst 12/1/2014
Cowen: With NASDAQ Index Up 33%, Biotech Remains a Winner 12/1/2014
e-Therapeutics plc Release: Research And Development Presentation To Investors And Analysts 12/1/2014
Perrigo Company plc Announces The Closing Of Its Registered Public Offering Of Ordinary Shares 11/26/2014
Cynapsus Therapeutics (CYNAF) Announces Uplisting To The Toronto Stock Exchange’s Senior Equity Market 11/26/2014
Alkermes plc (ALKS)’ Corporate Presentation To Be Webcast At The NASDAQ OMX 31st Investor Program 11/26/2014
Immune Pharmaceuticals, Inc. Announces Closing Of Public Offering Of Common Stock And Warrants 11/26/2014
Analyst: First Quarter of 2015 Crucial to ProSensa Holding N.V. (RNA), BioMarin Pharmaceutical Inc. (BMRN) Deal 11/25/2014
Perrigo Company plc Announces The Pricing Of Senior Notes Offering By Its Finance Subsidiary, Perrigo Finance plc 11/25/2014
AVANIR Pharmaceuticals (AVNR) Making Strides With Alzheimer’s Drug, Says Analyst 11/24/2014



//-->